Lawyer primes wrongful loss of life go well with tied to mislabeled CBD merchandise

A mix-up between CBD and THC products sold in Oregon has resulted in nine lawsuits against Curaleaf Holdings to date. A tenth lawsuit relating to an unjustified obituary relating to the mix-up of the two cannabis compounds is pending.

Portland attorney Michael Fuller, who represents all of the plaintiffs in these lawsuits, says his clients experienced confusion, dizziness, fear of death, and psychosis after consuming a product mistakenly labeled pure CBD tincture. In fact, they unknowingly consumed a significant amount of THC, the psychoactive ingredient in cannabis.

Fuller said one of his clients, Earl Jacobe, 78, of Christmas Valley, showed symptoms doctors thought was a stroke after he and his wife consumed the mislabeled products in August. In the weeks that followed, Jacobe had to be flown to hospital twice.

Jacobe’s family believe the episode weakened his mental and physical health “to the point where he was essentially comatose and then succumbed to unrelated COVID-19 disease a few weeks later,” Fuller said.

Much like Jacobe, Michael Lopez, 79, of Aloha, Oregon, had stroke-like symptoms, according to court documents. They say Lopez was taken to an emergency room by ambulance where he had “unnecessary operations, fear of death” and psychosis.

The Oregon Liquor Control Commission recalled hundreds of Select branded CBD tinctures from Cura Cannabis Solutions in September for having “unknown levels of THC” in them.

Oregon Liquor & Cannabis Commission

“We’re going to be doing individual studies for each person because each person’s experiences and injuries are a little different,” said Fuller. “We will try to colonize as many as possible. You see, a lot of my clients are older, in their late 70s; they are not interested in lengthy legal disputes. “

The Oregon Liquor Control Commission recalled hundreds of Select branded CBD tinctures from Cura Cannabis Solutions in September for having “unknown levels of THC” in them. Days later, the agency recalled hundreds of Select brand THC drops for not containing THC.

Portland-based Cura Cannabis CS was acquired in 2020 by Massachusetts-based Curaleaf Holdings, which is considered the world’s largest cannabis company by revenue. It is listed on the Canadian Stock Exchange and has a market capitalization of around $ 8.4 billion.

A representative from Curaleaf Holdings declined to comment on the litigation but made a statement regarding the mislabeled products

“A team member mistook two containers during the filling and packaging process, one with CBD and one with THC,” it says. “This resulted in a single batch of CDB tincture being labeled as a THC drop and vice versa. The amount of THC for our THC drops was within the legal limit for a normal batch, but we understand that some customers may have consumed multiple doses. “

The company is said to have implemented new controls to ensure such mix-up doesn’t happen again, including increased training and camera surveillance.

“We have also added a new quality technician role to Oregon, removing the person responsible for the error during the filling and packaging process,” it says.